JRCT ID: jRCT2080220116
Registered date:12/09/2005
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Colorectal cancer |
Date of first enrollment | 12/09/2005 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : Oxaliplatin | Tegafur-Gimeracil-Oteracil potassium capsule INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : Oxaliptatin:Infusion, Tegafur-Gimeracil-Oteracil potassium capsule:Oral |
Outcome(s)
Primary Outcome | To determine RD,calculate response rate at the RD |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 74age old |
Gender | Both |
Include criteria | Histologically proven colorectal cancer Unresectable and advanced colorectal cancer Neither prior chemotherapy,immunotherapy nor prior radiotherapy Age between 20 and 75 years old Performance Status(ECOG scale):0-1 |
Exclude criteria |
Related Information
Primary Sponsor | Yakult Honsha Co.,Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-050118 |
Contact
Public contact | |
Name | |
Address | TEL 813-5550-8966 FAX 813-3248-5502 |
Telephone | |
Affiliation | Yakult Honsha Co.,Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |